FMP

FMP

Enter

INFI - Infinity Pharmaceuti...

photo-url-https://images.financialmodelingprep.com/symbol/INFI.png

Infinity Pharmaceuticals, Inc.

INFI

NASDAQ

Inactive Equity

Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of metastatic triple negative breast cancer and urothelial cancer; and Phase 1/1b clinical trials for the treatment of solid tumors. The company has strategic alliances with Intellikine, Inc. to discover, develop, and commercialize pharmaceutical products targeting the delta and/or gamma isoforms of PI3K; Verastem, Inc. to research, develop, commercialize, and manufacture duvelisib and products containing duvelisib; and PellePharm, Inc. to develop and commercialize rights to its hedgehog inhibitor program, IPI-926, a clinical-stage product candidate, as well as collaboration agreements with Arcus Biosciences, Inc., F. Hoffmann-La Roche Ltd., and Bristol Myers Squibb Company. Infinity Pharmaceuticals, Inc. was incorporated in 1995 and is headquartered in Cambridge, Massachusetts.

0.008 USD

-0.0088 (-110%)

INFI Financial Statements

Year

2022

2021

2020

2019

CF from Operating Activities

-42.43M

-40.62M

-35.74M

-41.53M

Net Income

-44.37M

-45.26M

-40.49M

-47.06M

Depreciation & Amortization

458k

480k

483k

219k

Deferred Income Taxes

0

0

0

0

Stock Based Compensation

3.62M

2.69M

1.46M

2.13M

Change in Working Capital

-1.04M

2.21M

1.39M

1.38M

Accounts Receivable

0

0

0

0

Inventory

0

0

0

0

Accounts Payable

-300k

2.18M

882k

1.55M

Other Working Capital

-739k

37k

503k

-167k

Other Non-Cash Items

-1.1M

-745k

1.43M

1.79M

CF from Investing Activities

-55k

5.49M

14.63M

-12.24M

Investments in Property, Plant & Equipment

-17k

-11k

-43k

-2.33M

Net Acquisitions

0

0

0

0

Investment Purchases

-16.04M

0

-43.01M

-41.86M

Sales/Maturities of Investments

16M

5.5M

57.68M

31.95M

Other Investing Activites

0

0

0

0

CF from Financing Activities

73k

87.11M

27.44M

27.73M

Debt Repayment

0

0

0

0

Common Stock Issued

73k

87.11M

7.87M

112k

Common Stock Repurchased

0

0

0

0

Dividends Paid

0

0

0

0

Other Financing Activites

73k

87.11M

27.44M

27.73M

Free Cash Flow

-42.45M

-40.63M

-35.78M

-43.86M

Operating Cash Flow

-42.43M

-40.62M

-35.74M

-41.53M

Capital Expenditures

-17k

-11k

-43k

-2.33M

Cash at Beginning of Period

80.88M

28.91M

22.57M

48.62M

Cash at End of Period

38.47M

80.88M

28.91M

22.57M

Net Change In Cash

-42.41M

51.98M

6.33M

-26.04M

All figures are in USD.

FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedin
2017-2024 © Financial Modeling Prep